Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
spinoff
Biotech
Lupin seeds US spinout with cash, clinical-stage cancer assets
Kaveri’s programs hit targets pursued by major drugmakers including AstraZeneca, Bayer and Bristol Myers Squibb.
Nick Paul Taylor
Jul 21, 2026 8:20am
Adaptive plots split of drug discovery and diagnostics arms
Jun 16, 2026 9:24am
BioVie plans $20M IPO for spinout developing liver disease drug
Mar 17, 2026 5:18am
Atrium arises from Avidity buyout with $270M, preclinical assets
Feb 27, 2026 11:05am
Tiziana to spin out IL-6 drug, cites pharma interest in modality
Dec 2, 2025 8:45am
Evoq Therapeutics signs on with Sanofi in $500M partnership
Oct 16, 2025 10:25am
